Intensive Adjuvant Therapy for TNBC with BRCA Gene Mutation

Exclusion Criteria

• •Patients who are unable to take oral medication, or who refuse this medication regimen
• •Already enrolled in another study, or less than or equal to 4 weeks from discontinuation of another medication
• •Presence of severe dysfunction of vital organs
• •Patients with other malignancies (with the exception of cured non-melanoma skin cancers, carcinoma in situ of the cervix and other tumours that have been cured for at least 5 years)
• •Acute infectious disease or active chronic infectious disease
• •History of uncontrolled epilepsy, central nervous system disease or mental disorder